The deal creates a new force in the world of value-based health care.
Kaiser Permanente and Geisinger Health said Wednesday they agreed to create a new company called Risant Health, which plans on making more acquisitions in the years to come.
Under the deal, Geisinger would become a part of Risant and keep its name. The agreement is subject to federal and state regulators.
Like California-based Kaiser and Pennsylvania-based Geisinger, Risant would be a nonprofit; it would be headquartered near Washington, DC.
“In addition to Geisinger, Risant Health will grow its impact by acquiring and connecting a portfolio of like-minded, nonprofit, value-oriented community-based health systems anchored in their respective communities,” according to a statement put out by the companies.
According to The Wall Street Journal, Risant seeks to acquire 4 or 5 more hospital systems and get to total revenue of $30 billion to $35 billion over the next 5 years, and Kaiser is expected to provide about $5 billion in funding to Risant.
Risant Health will operate separately from Kaiser Permanente, while health systems that join the new firm will also retain distinct identities in their communities.
Jaewon Ryu, MD, JD, who became Geisinger’s CEO in 2019, will become the new CEO of Risant Health.
Geisinger includes 10 hospital campuses, a health plan with more than half a million members, and has more than 25,000 employees and more than 1700 employed physicians.
"Through Risant Health, we will make our value-based care expertise, technology and services available to community-based health systems, like Geisinger, to strengthen their ability to provide value-based care models with a focus on high-quality and equitable health outcomes," said Greg. A. Adams, chair and CEO, Kaiser Permanente, in the statement.
HS Treatment Goals: Better Quality of Life, Not Just Control
January 3rd 2025For part 3 of our discussion with Chris Sayed, MD, we tackle several important topics in the hidradenitis suppurative (HS) and inflammatory disease space: patient quality of life, medication and treatment goals, and the possibility of a cure.
Read More
Frameworks for Advancing Health Equity: Pharmacy Support for Non-Hodgkin Lymphoma
December 19th 2024Rachael Drake, pharmacy technician coordinator, University of Kansas Health System, explains how her team collaborates with insurance companies and providers to support treatment access for patients with non-Hodgkin lymphoma.
Listen